JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niv, D.
Right arrow Articles by Urca, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niv, D.
Right arrow Articles by Urca, G.

Anesthesia & Analgesia, Vol 87, 583-586, Copyright © 1998 by International Anesthesia Research Society


GENERAL ARTICLES

Antinociceptive effect induced by the combined administration of spinal morphine and systemic buprenorphine

D Niv, A Nemirovsky, J Metzner, V Rudick, I Jurna and G Urca
Department of Anesthesiology, Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University.

We evaluated the antinociceptive effect of combined spinal administration of morphine and systemic administration of buprenorphine. Experiments were performed on male Wistar rats. Nociception was measured using the tail immersion test. Buprenorphine was injected intraperitoneally (IP) and morphine was injected intrathecally (IT) via a catheter implanted in the subarachnoid space. Interaction of drugs was analyzed using a dose addition model. Both IT (1-5 microg) morphine and IP (50-500 microg/kg) buprenorphine increased the latencies of nociceptive responses in a dose-dependent manner. IT morphine (4 microg) and IP buprenorphine (100 microg/kg) produced 62.9+/-6.3 and 48.8+/-6.6 percent of the maximal possible effect (%MPE), respectively. The combined administration of 2 microg of IT morphine and 50 microg/kg IP buprenorphine produced a %MPE of 97.1+/- 3.4. The analysis of drug interaction revealed that IT morphine interacted with IP buprenorphine in a supraadditive manner while producing a potent antinociceptive effect. IMPLICATIONS: The concurrent administration of spinal morphine and systemic buprenorphine produces an antinociceptive effect that is greater than what could have been predicted from individual dose-response curves. This mode of interaction allows maintenance at a significant level of analgesia with reduced doses of opioids, which minimizes the incidence of undesirable side effects.


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
W. Zhang, Y. Ramamoorthy, R. F. Tyndale, and E. M. Sellers
INTERACTION OF BUPRENORPHINE AND ITS METABOLITE NORBUPRENORPHINE WITH CYTOCHROMES P450 IN VITRO
Drug Metab. Dispos., June 1, 2003; 31(6): 768 - 772.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. Nemirovsky, L. Chen, V. Zelman, and I. Jurna
The Antinociceptive Effect of the Combination of Spinal Morphine with Systemic Morphine or Buprenorphine
Anesth. Analg., July 1, 2001; 93(1): 197 - 203.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 1998 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1998 by the International Anesthesia Research Society.